SEC Filing Details

Form
DEF 14A
Filing Date
April 26, 2024
Document Date
June 21, 2024
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Copyright © 2024 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use